Veterinary Medicines

GABBROVET MULTI 140 MG/ML SOLUTION FOR USE IN DRINKING WATER/ MILK FOR PRE-RUMINANT CATTLE AND PIGS

Authorised
  • Paromomycin sulfate
Download as PDF

Product identification

Medicine name:
Gabbrovet Multi 140 mg/ml Oplossing voor gebruik in het drinkwater/in de melk
Gabbrovet Multi 140 mg/ml Solution pour administration dans l'eau de boisson/le lait
Gabbrovet Multi 140 mg/ml Lösung zum Eingeben über das Trinkwasser/die Milch
GABBROVET MULTI 140 MG/ML SOLUTION FOR USE IN DRINKING WATER/ MILK FOR PRE-RUMINANT CATTLE AND PIGS
Active substance:
  • Paromomycin sulfate
Target species:
  • Cattle (calf)
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Paromomycin sulfate
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for use in drinking water/milk
Withdrawal period by route of administration:
  • Oral use
    • Cattle (calf)
      • Meat and offal
        110
        day
      • Meat and offal
        20
        day
    • Pig
      • Meat and offal
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Cardboard box containing 1 bottle of 1 L containing a dosing device of 30 ml
  • Cardboard box containing 1 bottle of 500 ml containing a dosing device of 30 ml
  • Cardboard box containing 1 bottle of 250 ml containing a dosing device of 30 ml
  • Cardboard box containing 1 bottle of 125 ml containing a dosing device of 30 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0429/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 8/11/2022
Download
French (PDF)
Published on: 8/11/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 8/11/2022
Download
French (PDF)
Published on: 8/11/2022
Download
German (PDF)
Published on: 8/11/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."